{"entity":{"id":"kernis-health","kind":"company","name":"Kernis Health","aka":[],"tldr":"Kernis Health helps cancer patients keep their own living tumour tissue after surgery, instead of letting it be discarded, so it can be used later for functional drug testing, diagnostics and trial access.","summary":"Standard pathology fixes and kills tumour tissue after surgery. Kernis Health arranges for a patient's live tumour tissue to be preserved and owned by the patient, which opens the door to functional testing of drugs on their own cells, organoid growth, personalised therapies and clinical trials that need viable tissue. It is a California company in the Even One Ventures portfolio and also appears on the Sijbrandij Foundation's Future of Cancer Care Today list.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://kernis.health/"},{"label":"Even One Ventures portfolio","url":"https://evenone.ventures/"}],"tags":["startup","evenone-portfolio","oncology"],"related":[],"cancers":[],"sections":[],"technologies":["functional-drug-testing","organoids"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"California (city not published)","country":"US","companyType":"cro-services","website":"https://kernis.health/","stage":"startup","investors":["evenone-ventures"],"funding":[]},"route":"/companies/kernis-health/","neighbours":{"technology":[{"id":"functional-drug-testing","kind":"technology","name":"Functional (ex vivo) drug testing","route":"/technologies/functional-drug-testing/"},{"id":"organoids","kind":"technology","name":"Patient-derived organoids","route":"/technologies/organoids/"}],"company":[{"id":"evenone-ventures","kind":"company","name":"Even One Ventures","route":"/companies/evenone-ventures/"}]}}